ArisGlobal Announces Pharmacovigilance Solution
ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire.
ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire. Now known as ArisGlobal agBalance, the solution allows safety experts to directly engage in signal detection and drive the results through signals management into risk management. Regulators and the industry can access the integrated platform for detecting safety issues and communicating the changing benefit-risk profile of medicinal products to the health community in a timely manner.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025